Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

3.5K
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.5K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

5.5K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
5.5K
Bone Disorders01:29

Bone Disorders

4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
Structural Joints: Cartilaginous Joints01:17

Structural Joints: Cartilaginous Joints

2.6K
As the name indicates, at a cartilaginous joint, the adjacent bones are united by cartilage, a tough but flexible type of connective tissue. Unlike synovial joints, these types of joints lack a joint cavity and involve bones joined together by either hyaline cartilage or fibrocartilage.
There are two types of cartilaginous joints:
Synchondrosis
A synchondrosis ("joined by cartilage") is a cartilaginous joint where bones are connected by hyaline cartilage. Synchondrosis may be temporary...
2.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Consensus on the Management of Primary Localized Chordoma.

JAMA oncology·2026
Same author

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

Cancer research·2026
Same author

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: The Phase 2 DOREMY Nonrandomized Clinical Trial.

JAMA oncology·2026
Same author

Immune infiltration is associated with distinct transcriptional states and metabolic profiles in chordomas.

iScience·2026
Same author

Osteosarcoma 3D patient derived cultures to test genome-informed personalized treatment options: a feasibility study.

Frontiers in medicine·2026
Same author

Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium.

European journal of cancer (Oxford, England : 1990)·2026

Related Experiment Video

Updated: Sep 13, 2025

Development and Evaluation of a Rat Model of Full-Thickness Cartilage Defects
04:34

Development and Evaluation of a Rat Model of Full-Thickness Cartilage Defects

Published on: May 19, 2023

1.8K

Cartilage Tumors.

Suk Wai Lam1, Judith V M G Bovée1

  • 1Department of Pathology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, The Netherlands.

Surgical Pathology Clinics
|July 27, 2025
PubMed
Summary
This summary is machine-generated.

This review details common cartilage tumors, distinguishing benign from aggressive chondrosarcoma. Accurate diagnosis requires integrating clinical, radiological, histologic, and molecular data for precise identification.

Keywords:
Cartilage tumorsChondromyxoid fibromaChondrosarcomaEnchondromaIDH mutationOsteochondromaPeriosteal chondroma

More Related Videos

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

823
Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel’s Cartilage
06:40

Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel’s Cartilage

Published on: October 21, 2015

9.2K

Related Experiment Videos

Last Updated: Sep 13, 2025

Development and Evaluation of a Rat Model of Full-Thickness Cartilage Defects
04:34

Development and Evaluation of a Rat Model of Full-Thickness Cartilage Defects

Published on: May 19, 2023

1.8K
Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

823
Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel’s Cartilage
06:40

Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel’s Cartilage

Published on: October 21, 2015

9.2K

Area of Science:

  • Orthopedic Pathology
  • Skeletal Neoplasms

Background:

  • Cartilage tumors are a diverse group of neoplasms defined by cartilage production.
  • Benign cartilage tumors typically show slow growth, whereas chondrosarcomas are more aggressive.
  • Overlapping morphology necessitates integrated diagnostic approaches.

Purpose of the Study:

  • To provide a comprehensive overview of common cartilage tumors.
  • To discuss key diagnostic features and differential diagnoses.
  • To aid pathologists in recognizing noncartilaginous bone tumors with cartilaginous metaplasia.

Main Methods:

  • Literature review of cartilage tumors.
  • Analysis of diagnostic criteria for benign and malignant cartilage tumors.
  • Discussion of differential diagnoses including tumors with cartilaginous metaplasia.

Main Results:

  • Detailed description of common benign and malignant cartilage tumors.
  • Highlighting diagnostic challenges due to morphological similarities.
  • Emphasis on the importance of multimodal data integration.

Conclusions:

  • Accurate diagnosis of cartilage tumors relies on combining clinical, radiological, histological, and molecular findings.
  • Distinguishing benign tumors from chondrosarcoma is crucial for patient management.
  • Awareness of cartilaginous metaplasia in other bone tumors is essential for accurate pathological assessment.